NEWARK, N.J., Feb. 16, 2011 /PRNewswire/ -- OHK Medical Devices, Inc. announced today that it has selected Henry Schein Medical, the U.S. physician business of Henry Schein Inc. (Nasdaq: HSIC), the largest distributor of health care products and services to office-based dental, medical and veterinary practitioners, as the exclusive distributor of HemaClear® for the U.S. alternate care market. HemaClear is the first and only surgical tourniquet single-use device that exsanguinates, occludes, and provides a clearer surgical field.
"HemaClear is delighted to be partnering with a company that has such an excellent reputation for bringing its customers the highest quality and most innovative products on the market," said Oren Gavriely, Chief Executive Officer, OHK Medical Devices. "We are very much looking forward to bringing this new, revolutionary standard of care to Henry Schein customers around the country."
An exsanguination device that prepares any limb for surgery in less than 12 seconds, HemaClear provides a larger, dryer, and clearer surgical field, thereby providing the surgeon with a better view of anatomical structures. Its ease of use and simplicity saves valuable operating room time. HemaClear has been proven worldwide in over 180,000 surgical cases.
"Henry Schein Medical is pleased to exclusively offer HemaClear as part of our ongoing commitment to help drive the success of our customers' practices and enable them to provide the highest quality care," said Dave McKinley, President of Henry Schein Medical. "This innovative new technology is simple, sterile, safe, cost-effective, and ultimately provides more successful surgical outcomes, especially for our customers that practice in ambulatory surgical settings and perform office-based procedures."
About HemaClear
Manufactured by OHK Medical Devices, Inc., headquartered in Haifa, Israel, HemaClear® is the first self-contained, sterile, exsanguinating tourniquet that creates a bloodless field in seconds. HemaClear® performs three functions: blood removal (exsanguination), arterial flow occlusion, and automatic application of the sterile stockinet. HemaClear® replaces traditional devices, completely eliminating the need for a tourniquet machine, tourniquet cuff, Esmarch bandage, Webril™ and stockinet.
Perhaps most advantageous of all, from a logistics point of view, HemaClear® is self-contained and requires absolutely no connections or power source. HemaClear's innovative technology not only reduces blood loss, infection, and the volume of ischemic tissue, its simplicity saves precious operating room set-up time‚ as much as fifteen minutes‚ and over 10 separate steps and products that can save as much as $300 a procedure.
Hemaclear is used as a standard of care in over 25 countries and over 180,000 of Hemaclear's tourniquets have been applied. For more information, visit the HemaClear site at www.Hemaclear.com, or visit http://www.youtube.com/watch?v=L46SI03Lpl0
About Henry Schein
Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of health care products and services to office-based practitioners, is a Fortune 500® company and a member of the NASDAQ 100® Index. The Company is recognized for its excellent customer service and highly competitive prices. Henry Schein's five businesses – North American Dental, North American Medical, North American Animal Health, International and Technology – serve more than 700,000 customers worldwide, including dental practitioners and laboratories, physician practices and animal health clinics, as well as government and other institutions. The Company operates through a centralized and automated distribution network, which provides customers in more than 200 countries with a comprehensive selection of more than 90,000 national and Henry Schein private-brand products in stock, as well as more than 100,000 additional products available as special-order items. Henry Schein also provides exclusive, innovative technology offerings for dental, medical and veterinary professionals, including value-added practice management software and electronic health record solutions.
Headquartered in Melville, N.Y., Henry Schein employs more than 14,000 people and has operations or affiliates in 24 countries. The Company's net sales reached a record $6.5 billion in 2009. For more information, visit the Henry Schein Web site at www.henryschein.com.
SOURCE OHK Medical Devices, Inc.
Advertisement
"HemaClear is delighted to be partnering with a company that has such an excellent reputation for bringing its customers the highest quality and most innovative products on the market," said Oren Gavriely, Chief Executive Officer, OHK Medical Devices. "We are very much looking forward to bringing this new, revolutionary standard of care to Henry Schein customers around the country."
Advertisement
An exsanguination device that prepares any limb for surgery in less than 12 seconds, HemaClear provides a larger, dryer, and clearer surgical field, thereby providing the surgeon with a better view of anatomical structures. Its ease of use and simplicity saves valuable operating room time. HemaClear has been proven worldwide in over 180,000 surgical cases.
"Henry Schein Medical is pleased to exclusively offer HemaClear as part of our ongoing commitment to help drive the success of our customers' practices and enable them to provide the highest quality care," said Dave McKinley, President of Henry Schein Medical. "This innovative new technology is simple, sterile, safe, cost-effective, and ultimately provides more successful surgical outcomes, especially for our customers that practice in ambulatory surgical settings and perform office-based procedures."
About HemaClear
Manufactured by OHK Medical Devices, Inc., headquartered in Haifa, Israel, HemaClear® is the first self-contained, sterile, exsanguinating tourniquet that creates a bloodless field in seconds. HemaClear® performs three functions: blood removal (exsanguination), arterial flow occlusion, and automatic application of the sterile stockinet. HemaClear® replaces traditional devices, completely eliminating the need for a tourniquet machine, tourniquet cuff, Esmarch bandage, Webril™ and stockinet.
Perhaps most advantageous of all, from a logistics point of view, HemaClear® is self-contained and requires absolutely no connections or power source. HemaClear's innovative technology not only reduces blood loss, infection, and the volume of ischemic tissue, its simplicity saves precious operating room set-up time‚ as much as fifteen minutes‚ and over 10 separate steps and products that can save as much as $300 a procedure.
Hemaclear is used as a standard of care in over 25 countries and over 180,000 of Hemaclear's tourniquets have been applied. For more information, visit the HemaClear site at www.Hemaclear.com, or visit http://www.youtube.com/watch?v=L46SI03Lpl0
About Henry Schein
Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of health care products and services to office-based practitioners, is a Fortune 500® company and a member of the NASDAQ 100® Index. The Company is recognized for its excellent customer service and highly competitive prices. Henry Schein's five businesses – North American Dental, North American Medical, North American Animal Health, International and Technology – serve more than 700,000 customers worldwide, including dental practitioners and laboratories, physician practices and animal health clinics, as well as government and other institutions. The Company operates through a centralized and automated distribution network, which provides customers in more than 200 countries with a comprehensive selection of more than 90,000 national and Henry Schein private-brand products in stock, as well as more than 100,000 additional products available as special-order items. Henry Schein also provides exclusive, innovative technology offerings for dental, medical and veterinary professionals, including value-added practice management software and electronic health record solutions.
Headquartered in Melville, N.Y., Henry Schein employs more than 14,000 people and has operations or affiliates in 24 countries. The Company's net sales reached a record $6.5 billion in 2009. For more information, visit the Henry Schein Web site at www.henryschein.com.
SOURCE OHK Medical Devices, Inc.
